Innoviva (INVA) Amortization - Intangibles (2014 - 2026)
Innoviva (INVA) posted Amortization - Intangibles of $6.6 million for Q1 2026, down 66.56% on a QoQ basis from $19.6 million in Q3 2025, and up 1.22% year-over-year from $6.5 million in Q1 2025.
Innoviva (INVA) Amortization - Intangibles (2014 - 2026) Analysis & Trends
Innoviva's Amortization - Intangibles history runs 6 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- Quarterly Amortization - Intangibles rose 1.22% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.1 million (up 1.09% YoY) and the FY2025 annual result came in at $26.3 million, up 1.45% from the prior year.
- Amortization - Intangibles was $6.6 million for Q1 2026 at Innoviva, down from $19.6 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $19.6 million in Q3 2025 and bottomed at $1.5 million in Q3 2022.
- A 5-year average of $8.8 million and a median of $6.5 million in 2025 frame the typical range for Amortization - Intangibles.
- Annual changes were most pronounced in 2023 — Amortization - Intangibles jumped 912.57% — and 2025, when it increased 0.54%.
- Innoviva's Amortization - Intangibles stood at $1.5 million in 2022, then soared by 912.57% to $15.3 million in 2023, then gained by 26.74% to $19.4 million in 2024, then grew by 1.08% to $19.6 million in 2025, then plunged by 66.56% to $6.6 million in 2026.
- Business Quant data shows INVA's Amortization - Intangibles at $6.6 million in Q1 2026, $19.6 million in Q3 2025, and $6.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.55 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Jun 30, 2025 | 6.50 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Sep 30, 2024 | 19.39 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 6.44 Mn |
| Sep 30, 2023 | 15.30 Mn |
| Jun 30, 2023 | 4.96 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Sep 30, 2014 | 3.23 Mn |